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Abstract
The adenosinergic system is essential in the mediation of intrinsic protection and myocardial resistance to insult; it may be
considered a cardioprotective molecule and adenosine receptors (ARs) represent potential therapeutic targets in the setting
of heart failure (HF). The aim of the study was to test whether differences exist between mRNA expression of ARs in the
anterior left ventricle (LV) wall (pacing site: PS) compared to the infero septal wall (opposite region: OS) in an experimental
model of dilated cardiomyopathy. Cardiac tissue was collected from LV PS and OS of adult male minipigs with pacing-
induced HF (n = 10) and from a control group (C, n = 4). ARs and TNF–a mRNA expression was measured by Real Time-PCR
and the results were normalized with the three most stably expressed genes (GAPDH, HPRT1, TBP). Immunohistochemistry
analysis was also performed. After 3 weeks of pacing higher levels of expression for each analyzed AR were observed in PS
except for A1R (A1R: C = 0.660.2, PS = 0.160.04, OS = 0.0460.01, p,0.0001 C vs. PS and OS respectively; A2AR: C = 1.0460.59,
PS = 2.6260.79, OS = 2.9960.79; A2BR: C = 1.260.1, PS = 5.5962.3, OS = 1.5960.46; A3R: C = 0.7660.18, PS = 8.4063.38,
OS = 4.4060.83). Significant contractile impairment and myocardial hypoperfusion were observed at PS after three weeks of
pacing as compared to OS. TNF-a mRNA expression resulted similar in PS (6.362.4) and in OS (5.962.7) although higher
than in control group (3.461.5). ARs expression was mainly detected in cardiomyocytes. This study provided new
information on ARs local changes in the setting of LV dysfunction and on the role of these receptors in relation to pacing-
induced abnormalities of myocardial perfusion and contraction. These results suggest a possible therapeutic role of
adenosine in patients with HF and dyssynchronous LV contraction.
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Introduction
Adenosine derives from ATP degradation; it is considered to
play an important role in adaptation to inadequate oxygen supply
since it accumulates under hypoxic or ischemic conditions [1–3].
Adenosine concentration measurement is known to be technically
difficult since it is rapidly degraded into inosine. Basal adenosine
levels reported in myocardial interstitial fluid range from nano- to
micromolar concentrations; maximal ATP-derived adenosine
production might reach 100 nmol adenosine/(h.heart) in the case
of oxygen shortage [4,5]. The diverse cellular actions of adenosine
are mediated by a family of adenosine receptors (ARs); four
subtypes (A1R, A2AR, A2BR and A3) have been cloned and
pharmacologically characterized [6,7].
Evidence indicates that the adenosinergic system is essential in
the mediation of intrinsic protection and in determining myocar-
dial resistance to insult; therefore, adenosine may be considered as
a potential cardioprotective molecule and ARs could represent
potential therapeutic targets in the setting of heart failure (HF).
In a previous study, it was shown that AR subtypes are
ubiquitously distributed in cardiac tissue and up-regulated in the
left ventricle (LV) after 3 weeks of pacing in a model of pacing-
induced HF in pigs [8].
A study carried out in our Institute demonstrated that high-
frequency pacing of the LV free wall causes a dyssynchronous
pattern of activation that contributes to progressive cardiac failure,
with pronounced differences in regional contractility and flow but
global abnormalities in myocardial metabolism [9].
Efficient LV chamber performance relies also on coordinated
contraction of LV walls; a dyssynchronous pattern of activation -
as observed during pacing in experimental models- contributes to
progressive cardiac failure and can be related to what frequently
reported in clinical practice in patients with conduction abnor-
malities who are more prone to develop left ventricular
dysfunction [10].
The aim of the study was to test in this animal model of pacing-
induced HF whether regional differences exist in ARs mRNA
expression at pacing site (PS) as compared to the opposite wall
PLOS ONE | www.plosone.org 1 October 2012 | Volume 7 | Issue 10 | e47011
(OS) and whether these differences possibly depend on regional
abnormalities of myocardial contractility and perfusion.
Materials and Methods
Pacing protocol and tissue collection
Cardiac tissue was collected from two different sites of the LV of
male adult minipigs (weight 35–40 Kg) with pacing-induced HF
(n = 10).
Left intercostal thoracotomy was performed under general
anesthesia and sterile conditions. An aortic catheter was surgically
inserted in the descending aorta and an unipolar screw-type
epicardial pacing lead was connected to the anterior LV free wall.
A programmable pacemaker was implanted in a subcutaneous
pocket. After surgery, the minipigs were allowed to fully recover
for 10 days. Next, HF was induced by rapid LV pacing (180 beats/
min) for 3 weeks. The cardiovascular function was monitored as
previously described [9] and minipigs were considered to be in HF
when the LV end-diastolic pressure was $20 mmHg and LV
ejection fraction was ,25%.
All animals underwent hemodynamic evaluation (heart rate,
mean aortic pressure, left ventricular pressure and dP/dtmax) at 10
days after surgery (baseline) and after 3 weeks of LV pacing.
Global and regional myocardial contractility was assessed by
magnetic resonance imaging (MRI, 1.5 Tesla) at baseline and at
the end of the experimental protocol as previously described [9].
Finally the animals were deeply sedated with 3.3 mg/kg of
propofol and sacrificed by injecting saturated KCl solution
(10 ml). Cardiac tissue samples were collected from the anterior
left ventricular wall, PS, and from the infero septal wall, (OS). The
samples were immediately placed in ice-cold RNAlater and stored
at 280uC.
Cardiac tissue (left ventricular wall) was also collected from male
adult minipigs without (n = 4) pacing-induced HF as control group
(C).
These procedures were approved by the Italian Ministry of
Health in accordance with the Italian law (DL-116,27 January
1992), which conforms to the Guide for the Care and Use of
Laboratory Animals published by the US National Institute of
Health (NIH publication nu 85-23, revised 1996).
Hemodynamic recordings
The aortic catheter was attached to a strain-gauge transducer to
measure arterial pressure [9].
LV pressure and dP/dtmax values were measured using a
calibrated pressure catheter (Millar Instruments Inc, Houston,
TX, USA) inserted percutaneously into the LV cavity under
fluoroscopy guidance in animals lightly sedated with continuous
infusion of midazolam (0.1 mgNkg21Nh iv) at spontaneous breath-
ing [11]. All analogical signals were recorded and stored in a
computer memory through an analog-digital interface (National
Instruments), at a sampling rate of 250 Hz for subsequent analysis.
Cardiac MRI
As previously described, cine-MRI images were acquired with a
1.5 Tesla MRI scanner (Signa Excite HD, GE Medical System-
s,Waukesha, WI, USA) in sedated animals with continuous
infusion of midazolam (0.1 mgNkg21Nh iv) at spontaneous heart
rate. Global LV parameters (end-diastolic volume, end-systolic
volume and ejection fraction) were analyzed in pacing-induced HF
with a commercially available research software package (Mass
Analysis, Leyden, The Netherlands) [9,12–14].
Regional LV myocardial perfusion was evaluated with the first-
pass MRI technique by the LV relative upslope of signal intensity
(LVRUSI, myocardial upslope divided LV cavity upslope) for each
myocardial segment, obtained after a bolus injection of gadolin-
ium-diethylenetriamine pentaacetic acid (0.05 mmol/Kg at 4 ml/
s of infusion velocity iv Gd-DTPA; Magnevist, Schering, Berlin,
Germany) in a peripheral vein [9,12].
To regionally assess the presence of tissue fibrosis, gadolinium-
delayed contrast-enhanced images were acquired in two-dimen-
sional segmented inversion recovery-prepared gradient echo
sequence 10 min after administration of the contrast agent Gd-
DTPA (0.2 mmol/kg iv) in short-axis views [9,12–14].
Molecular analysis
RNA extraction. Total RNA was extracted by acid guanidi-
nium thiocyanate-phenol-chloroform method from tissue samples
obtained from pig hearts with the Rneasy Midi kit (Qiagen S.p.A,
Milano, Italy) as previously described [8,15–17]. RNA concen-
tration was determined spectrophotometrically (Biophotometer
Eppendorf) at 260 nm. The ratio of readings at 260 nm and
280 nm (A260/A280) provided an estimate of the purity of RNA.
The integrity and purity of total RNA was also detected by
electrophoresis of samples on ethidium bromide agarose gels. Only
the samples that showed clear and distinct 28S and 18S ribosomal
RNA bands and had spectrophotometric OD 260/280 ratios of
1.9–2.1 were used. A known amount of total RNA (Ambion) was
used as marker. The RNA samples were stored at 280uC for use
in gene expression studies.
Real Time quantitative RT-PCR. Following DNAse treat-
ment, first strand cDNA was synthesized with iScript cDNA
Synthesis kit (Bio-rad, Hercules, California, USA) using about
1 mg of total RNA as template.
Real-time PCR was conducted on a 96-well iQ Cycler Real-
Time PCR Detection System (Biorad, Hercues, CA, USA) in a
25 ml final volume, using 12.5 ml of iQ SYBR Green Supermix 2X
(Biorad, Hercues, CA, USA) and 2 ml of cDNA as template. In
general, the amplification protocol started with 95uC/3 min
followed by 40 cycles of 95uC/15 s and 60uC/30 s. Annealing
temperature varied depending on the primer pair used (Table 1).
Two no template controls were used in each PCR run, while two
inter-run calibrators were used to ensure the comparability of
different PCR runs.
A series of PCRs was performed on cDNAs of HF pigs (PS and
OS respectively) using primer pairs for A1R, A2AR, A2BR, A3R
and TNF-a. Primer pairs were designed with Primer Express
Version 2.0 (Applied Biosystems) and details are given in Table 1.
Specificity of each primer pair, i.e., absence of artifacts, multiple
PCR products or primer-dimers, and PCR yield were checked by
agarose-gel electrophoresis and by melting analysis. All reactions
were performed in triplicate.
Immunohistochemistry analysis
Myocardial tissue samples were paraffin-embedded, cut into 5-
mm-thick sections, mounted serially on glass slides and treated for
immunohistochemistry as previously described [18].
A3R expression was detected using a rabbit anti-human
adenosine A3R antibody (ADORA3, MBL International Corpo-
ration, MA, USA) diluted 1:100 in BSA-PBS. This antibody reacts
with pig A3R on paraffined sections as specified by the supplier.
For each selected specimens, at least three serial sections 1/10
were examined using semi-quantitative scale of immunoreactivity:
no (2), low (+), medium (++) and high (+++) staining. Negative
controls were obtained by incubating the specimens with BSA-
PBS, omitting the primary antibody. Representative photomicro-
graphs were taken by a DFC480 digital camera (Leica Micro-
system, Cambridge, UK).
ARs mRNA Expression in Pacing-Induced HF
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Data Analysis
The geometric mean of the three most stably expressed genes
(GAPDH, HPRT1,TBP), selected in previous studies [8,19], was
confirmed in this new set of experiments where C, PS and OS
samples were considered as a single system which was used for
normalization of each gene mRNA expression in the samples.
The relative quantification was performed by DDCt method
using iQ5 Software (BioRad, Hercules, CA, USA).
Differences between more than two independent groups were
analyzed by Fisher’s test after ANOVA. The results were




As shown in Table 2, after 3 weeks of pacing the animals
showed an increased heart rate and a marked decrease in mean
arterial pressure and LV end-systolic pressure.
In all animals LV end diastolic pressure was at least 20 mmHg
which was considered an index of severe, although not end-stage,
HF.
Cardiac MRI
At the end of the experimental protocol global LV ejection
fraction was significantly reduced (35.963 vs. 7662%, p,0.05).
In particular, LV end-systolic wall thickening (LVESWT), an
index of regional contractile function, was significantly lower in the
PS than in the OS (5.3162.08 vs. 45.0464.18, p,0.001),
indicating a severe regional pacing-induced contractile impair-
ment. The LVRUSI was more reduced in the PS than in the OS
(9.161 vs. 14.661.2%, p,0.05), suggesting a significant myocar-
dial hypoperfusion in the abnormally contracting area. No
changes between LV PS and OS were reported for gadolinium-
delayed enhancement, suggesting lack of significant tissue fibrosis.
ARs, and TNF-a mRNA expression in PS and OS
In Fig. 1 the mean values obtained for A1R, A2AR, A2BR and
A3R mRNA expression at PS, OS in HF animals and in C, are
reported.
After 3 weeks of pacing higher levels of expression for each ARs
were observed in PS except for A1R; for this subtype a significant
mRNA reduction was found both in PS and in OS (p,0.0001,
respectively).
Higher levels of A1R, A2BR and A3R although not statistically
significant were observed in PS as compared to OS. A2AR were
almost comparable in the two sites.
TNF-a mRNA expression resulted similar in PS (6.362.4) and
in OS (5.962.7) in HF minipigs, although higher than in the
control group (3.461.5).
A very significant correlation was also found between overall
A2BR and A3 (r = 0.88, p,0.0001).
Immunohistochemistry
To confirm mRNA expression of the AR receptors, myocardial
A3 expression was assessed by immunohistochemistry.
As showed in Fig. 2 A3R immunohistochemical expression
reaction (brown) was greater in PS (+++) than OS (++) and C (+)
while the negative control was not immunoreactive (2).
Discussion
In a previous study [8] performed in the same experimental
model, an up-regulation of ARs in the left ventricle was found, as
compared to controls, after 3 weeks of sustained high frequency
LV pacing. While 7-5-2 fold increase was observed for A2BR, A3R
and A2AR, with respect to the control group, A1R showed a slight
increase; however, whether the myocardial expression of ARs
would relate to the regional distribution of LV contractile
dysfunction was not assessed.
In the current investigation the ARs mRNA expression was
evaluated in the PS and in the OS of an animal model of non-
ischemic dilated cardiomyopathy induced by LV pacing at high
frequency as well as in a group of healthy animals. ARs expression
in the regions of interest of the LV myocardium was assessed and a
receptor up-regulation in the PS was found compared to OS. The
trend of ARs mRNA expression previouslydetermined [8] in
control group vs. HF animals in the left ventricle was confirmed
except for A1R mRNA which resulted significantly reduced both
in PS and in OS, probably due to the larger number of studied
animals.
ARs are known to be activated by interstitial physiological or
supraphysiological concentration levels of adenosine [5]. As




A1R 59- ATCAGGTTACTTGGTTCT -39
59- ATCAGGTTACTTGGTTCT -39
57u AY772411
A2AR 59- GATCAGCCTCCGCCTCAACGGCCA -39
59- TCAGGACACTCCTGCTCTGTCCTG -39
60.5u AY772412
A2BR 59- TGGTGTACTTCAACTTCCTG -39
59- GATCTTGGCGTAGATGGC -39
60u AY772413
A3R 59- GGTGAAGTGCCAGAAGTTGTG -39
59- AGCATAGACGATAGGGTTCATCAT -39
60u AY772414
TNF-a 59- TGACCACCACCAAGAATT -39
59- TGTTCTGAAGTATTCCGATTG -39
60u NM_214022
GAPDH 59- TCGGAGTGAACGGATTTG -39
59- CCTGGAAGATGGTGATGG -39
59u AF017079
HPRT1 59- CCGAGGATTTGGAAAAGGT -39
59- CTATTTCTGTTCAGTGCTTTGATGT -39
60u DQ178126
TBP 59- GATGGACGTTCGGTTTAGG -39
59- AGCAGCACAGTACGAGCAA -39
59u DQ178129
Primer pair used for housekeeping and target genes in Real Time experiments.
A1R = adenosine 1 receptor A2AR = adenosine 2A receptor, A2BR = adenosine 2B
receptor, A3R = adenosine 3 receptor, TNF-a= tumor necrosis factor - a,
GAPDH=Glyceraldehyde 3-phosphate dehydrogenase, HPRT1 =Hypoxanthine
PhosphoRibosylTransferase 1, TBP = TATA-Binding protein.
doi:10.1371/journal.pone.0047011.t001
Table 2. Hemodynamic parameters in controls and HF
animals (after 2162 days of pacing).
Controls HF
HR, beats/min 9267.2 108.568.64 p,0.0001
LVEDP, mmHg 7.460.85 21.563.26 p = 0.0002
MAP, mmHg 101.1610.7 81.8610.8 p,0.0001
LVDP/dmax, mmHg/s 2064.26115.9 1536.16151.1 p,0.0001
LVESP, mmHg/s 116.1612.4 95.068.25 p,0.0001
HR: heart rate, LVEDP: left ventricular end-diastolic pressure, MAP: mean arterial
pressure, LVESP: left ventricular systolic pressure.
doi:10.1371/journal.pone.0047011.t002
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observed in different models exposed to varying concentrations of
an A1R agonist, a rapid internalization of A1R is possible, leading
to receptor desensitization [20,21].
The lower level of A1R observed in this study both in PS and
OS after HF induction could be due to a desensitization of A1R
caused by higher adenosine concentration. These results are in line
with a previous study in which agonist-induced cell surface A1R
Figure 1. Adenosine receptors mRNA expression in left ventricle of normal and HF minipigs. a) A1R, b) A2AR, c) A2BR and d) A3R mRNA
expression measured by Real Time PCR in the left ventricle of controls (C) (white bars), in the anterior left ventricular wall (PS) (grey bars) and in the
opposite site (OS) (black bars) of HF minipigs. The result were expressed as mean 6 SEM.
doi:10.1371/journal.pone.0047011.g001
Figure 2. A3R immunohistochemical expression. Immunohistochemical staining of A3R in the left ventricle of controls (C), in the anterior left
ventricular wall pacing site (PS) and in the opposite site (OS) of HF minipigs. Negative control was inserted in the right side of PS image. Scale bar:
50 mm.
doi:10.1371/journal.pone.0047011.g002
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aggregation with subsequent receptor desensitization and inter-
nalization was demonstrated [20].
The reduction in pump function after high frequency ventric-
ular pacing is due not only to tachycardia but also to the abnormal
electrical activation which determines the loss of the normal apex-
to-base sequence of activation, as seen during normal sinus
rhythm, leading to an asyncronous contraction of the different
parts of the left ventricular myocardium [22–24].
After a few weeks of continuous high-frequency pacing,
myocardial perfusion was markedly impaired, especially in regions
with a more pronounced contractile derangement.
The semi-quantitative MRI assessment showed higher perfusion
levels in the OS relative to the PS while no differences could be
found in terms of tissue fibrosis between LV PS and OS by
gadolinium-delayed enhancement techniques.
Our findings provide the first evidence of regional differences in
ARs mRNA expression in a dysfunctioning heart with LV
asynchronous contraction.
Although the lack of statistically significant values may limit the
strength of the results, the trend observed at the two LV walls and,
mostly, the influence of pacing on local perfusion and contractility,
together with the differences with controls, may provide important
information on local receptor expression in this widely used
experimental model.
The long-term asynchrony and impairment in LV contractile
performance seem to exert a positive feedback on the transcription
of genes coding for myocardial adenosine receptors not associated
with collagen synthesis.
Adenosine protects the heart during ischemia via the activation
of A1R and A3R [25], increasing coronary blood flow via the
activation of A2AR, improving contractile performance and
inhibiting cytokine production and inflammatory response [26,27].
In this study A1R, A2BR and A3R mRNA expression resulted
higher in the PS than in the OS; the lower myocardial levels of
ARs in OS could be in tune with the presence of better myocardial
contraction and perfusion in this region as compared to PS.
These results are confirmed by immunohistochemistry and are
in agreement with a previous study where higher ATP consump-
tion and better mechanical activity in the OS of a failing heart was
observed [28].
The higher TNF-a levels found in HF animals as compared
with controls support the hypothesis of the interaction between
adenosine and TNF-a in the initiation, maintenance and
amplification of the inflammatory response [8].
This model, devoid of possible confounding effects of pharma-
cological therapy, allowed the evaluation of alterations of ARs in
the setting of LV dysfunction and provided new data on the role of
these receptors in relation to pacing-induced abnormalities in
myocardial perfusion and contraction. These results suggest a
possible therapeutic role of adenosine in patients with heart failure
and dyssynchronous contraction. Chronic dyssynchrony pro-
foundly affects [10,29] and accelerates the progression of heart
failure and represents the rationale of resynchronization therapy to
reduce the burden of incoordinate LV contraction [30]. It could
be hypothesized that in HF patients with normal coronary arteries
and LV dyssynchrony, adenosine might represent a possible
therapeutic approach to slow down or even revert the develop-
ment of heart failure.
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